Navigation Links
FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
Date:2/27/2009

CORT as a treatment option to manage their symptoms and help control the disease over time."

About COPD

In patients with severe to very severe COPD, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends the addition of inhaled corticosteroids (ICS) to long-acting beta2-agonists (LABA), in addition to other treatment options.(6) Common symptoms of COPD include shortness of breath, chronic cough, wheezing and excess mucus.(4) COPD is a progressive disease, which means people with COPD can expect lung function to worsen over time.(6) When symptoms are severe, it can be difficult for a person to perform simple, daily tasks.(4) As the disease progresses, people with COPD may eventually require long-term oxygen therapy.(6)

About SYMBICORT

SYMBICORT 160/4.5 mcg is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.(2) For patients with COPD, the approved dosage of SYMBICORT is 160/4.5 mcg two inhalations twice daily. SYMBICORT is also indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older.(2) Administered twice daily,(2) SYMBICORT is a combination of two proven respiratory medications - budesonide, an inhaled corticosteroid (ICS), and formoterol, a rapid and long-acting beta2-agonist (LABA).(2) SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of COPD or asthma.(2)

Important Safety Information

Lower respiratory tract infections, including pneumonia, have been reported following the inhaled administration of corticosteroids. In two placebo-controlled SYMBICORT COPD clinical studies, pneumonia did not occur with greater incidence in the SYMBICORT 160/4.5 group compared with placebo, while the incidence of lung infections other than pneum
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
2. European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
3. Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects
4. FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
5. FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
6. FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
7. Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
8. Monsanto Board Approves 10 Percent Dividend Increase
9. FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
10. MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --
11. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... N.H. , April 1, 2015 Emerson ... IGNITE: The Business of Better Medicine . The ... business knowledge to develop a thriving and fulfilling practice. ... the Omni La Costa Resort and Spa, the conference ... attendees can expect to accomplish key projects and leave ...
(Date:4/1/2015)... 1, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") ... pleased to announce that Biohaven Pharmaceutical Holding Company ... entered into an agreement with inVentiv Health for ... with their lead compound (BHV-0223). ... of clinical stage neuroscience compounds targeting the glutamatergic ...
(Date:4/1/2015)... Canada,s Research-Based Pharmaceutical Companies (Rx&D) acknowledges ... on Cost Drivers of Public Drug Plans in ... the rates of change in drug costs have been steadily ... in 2012/13 for a number of select public drug plans. ... of medicines without considering their overall impact on the system ...
(Date:4/1/2015)... 2015 Holomic is introducing the HRDR-400, ... chromatographic and fluorescent rapid tests with one device. ... quantitative readers and is already selling its HRDR-200 chromatographic ... first of its kind offering for manufacturers and end-users ... Dr. Neven Karlovac, CEO of Holomic LLC, commented, "We ...
Breaking Biology Technology:Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 2Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 3Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2
... AMSTERDAM, August 17 SynCo Bio Partners, ... a strategic partnership to produce Versartis, lead drug candidate,VRS-859, ... type 2 diabetes,Under the agreement, SynCo will further develop ... manufacturing process to,increase yields for the forthcoming cGMP production. ...
... , , , ... BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading manufacturer ... today announced that it has entered into a non-exclusive distribution ... STEMCELL Technologies, a member of the StemCell Group of companies, ...
... MD, and Christchurch, NZ June 25, 2009 ... detection solutions, today reported that new independent data to ... the exceptional accuracy of its Ceeker (pronounced "seeker") portable ... similar-looking hoax substances. The data show that in ...
Cached Biology Technology:SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 3Novel handheld device detects anthrax with outstanding accuracy and reliability 2Novel handheld device detects anthrax with outstanding accuracy and reliability 3
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
(Date:3/5/2015)... In Brazil , cloud computing ... these solutions and 42 percent planning to invest in them ... percent of the companies will be investing in these solutions ... companies in the region are currently opting for the private ... command significant attention in the coming years. This trend is ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... In a first-of-its-kind clinical trial, physician-scientists at University Hospitals ... Western Reserve University School of Medicine are studying a ... five-year study is recruiting patients to compare the effectiveness ... large colon polyps. SDNA is a ...
... geneticist Alexander Varshavsky (California Institute of Technology, USA), who was ... 1977, has been awarded the Otto Warburg Medal of the ... is considered to be the highest German award for biochemists ... carried out with yeast and cell cultures of higher organisms, ...
... addition to being among his most vibrant and celebrated works, ... mutation whose genetic basis has, until now, been a bit ... (March 29) in the journal PLoS Genetics , however, ... behind the distinctive, thick bands of yellow "double flowers" that ...
Cached Biology News:New clinical trial explores novel noninvasive colon cancer screening test 2New clinical trial explores novel noninvasive colon cancer screening test 3Otto Warburg Medal for Alexander Varshavsky 2Otto Warburg Medal for Alexander Varshavsky 3UGA scientists reveal genetic mutation depicted in van Gogh's sunflower paintings 2
... 19 x 29 cm, 1. One ... staining of Coomassie Blue or silver-stain gels ... blots for high sensitivity ECL detection and ... volume, and processing time.Proven design for consistent, ...
Complement C1r [Human]...
Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
... oligos for SYBR Green, TaqMan, LNA spiked ... assays. Highly specific primers are designed by ... BLAST search results. Primer efficiency is enhanced ... connecting to the Mfold server. Beacon Designer ...
Biology Products: